Committee Mission
The mission of the Donor Issues Committee is to recommend to the Executive Committee policies, programs, and actions pertaining to the identification of stem cell donors (bone marrow, peripheral blood, and cord blood), harvesting procedures, product transportation, donor safety practices, and outcomes / long term follow-up within a member collection center; this includes the conduct of individuals and processes related to these procedures and practices.
Meetings & Teleconfereces
The Donor Issues Committee meets annually. The Donor Issues Committee has organized four Donor Outcome Workshops. Workshops have been in Bern, Leiden, Vienna, Tel Aviv.
Completed Projects
The Donor Issues Committee completed the following projects:
- Joint WBMT/EBMT webinar on Haploidentical family donors with special respect to minors as donor.
- Find more information on EBMT website
- Allogeneic hematopoietic stem cell donation – standardized assessment of donor outcome data:
- A consensus statement from the Worldwide Network for Blood and Marrow Transplantation
- Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations.
- Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association
- Suitability criteria for adult related donors:
- a consensus statement for the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues
- Position Statement of WBMT:
- Coalition says PBSC donor compensation poses health risks to patients and donors
- Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective:
- the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ongoing Projects
The Donor Issues Committee continues to work on the following projects:
- Develop suitability criteria of donors with risk for infectious diseases (travel history) or living in areas of endemic infectious diseases.
- Donor Follow Up and Serious Adverse and Events reporting in different countries.
- We would like to understand the influence of G-CSF mobilization on the clinical presentation of Covid-19 in patients or related donors who were subsequently found to be infected. By filling in this questionnaire you agree that the compiled data will be published with no individual center identification. All centers responding to the questionnaire will be acknowledged. Because we expect it to be a rare event, we also ask your permission to contact you again for more detailed information on the follow up of these patients/donors.
- Link to questionnaire
Want to join us?
Send an e-mail to mail to mail@wbmt.org